ML Solutions
ML Solutions
Predictive Analytics For Precision Medicine

Harnessing Machine Learning to accurately predict effectiveness of cancer treatments


Our partnership with GenomiQa will drive the development of predictive analysis tools to enhance patient care. Initial areas of collaboration will include developing improved models to predict how individual patients are likely to respond to various cancer treatments. This ground-breaking partnership puts Max Kelsen and Australia at the global forefront of integrating whole-genome sequencing and AI into clinical practice.

About GenomiQa

Born out of the world-renowned QIMR Berghofer Medical Research Institute, GenomiQa offers hospitals, clinicians and companies high-quality analysis of genomic data to inform healthcare decisions. When it launched in 2017, GenomiQa became the first company in Australia to specialise in the analysis of whole-genome cancer data. GenomiQa’s founders are world leaders in the field of genome analytics, and a 2015 study in Nature Communications identified the company’s pipeline as one of the top performers globally.


Explore More

Case Studies that share common themes and challenges.

Transforming Gut Health with Google Cloud and Microba

Transforming Gut Health with Google Cloud and Microba

ML SolutionsArrow